LLY

Eli Lilly and Company

Halal Rating :
Uncomfortable
Last Price $728.00 Last updated:
Market Cap $656.78b
7D Change -8.71%
1 Year Change 15.39%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 30, 2024

Eli Lilly and Company is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company discovers, develops, manufactures, and sells pharmaceutical products worldwide. Their product portfolio includes treatments for diabetes, cancer, immunological disorders, neurological disorders, and other serious medical conditions.

The company's key business segments include human pharmaceutical products and animal health products under their Elanco division. They focus on areas including diabetes, oncology, immunology, neurodegeneration, and pain.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $11.44b $9.91b - - 0.00% 0.00%
June 30, 2024 $11.3b $7.59b - - 0.00% 0.00%
March 31, 2024 $8.77b $6.26b - - 0.00% 0.00%

Company Impact

Help us evaluate Eli Lilly and Company's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates